Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trials.
Journal: BMJ oncology
Published: December 16, 2025
Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities.
Journal: NPJ precision oncology
Published: December 19, 2023
Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas.
Journal: Journal of clinical medicine
Published: October 28, 2022
Cancer T-cell therapy: building the foundation for a cure.
Journal: F1000Research
Published: December 16, 2020
Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma: A Review.
Journal: JAMA oncology
Published: November 08, 2019
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: November 10, 2018
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.
Journal: The Lancet. Oncology
Published: November 07, 2018
CAR T-Cell Therapy in Large B-Cell Lymphoma.
Journal: The New England journal of medicine
Published: March 15, 2018
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Journal: The New England journal of medicine
Published: December 12, 2017
Last Updated: 09/26/2026